[Case Study] Keiji Okinaka “A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment” (AMR Alliance Japan, September 6, 2021 )
date : 9/6/2021
Tags: AMR
AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) has begun a project to publish case studies showing actual cases in which antimicrobials were and were not used as examples of antimicrobial stewardship.
In this first case study, Dr. Keiji Okinaka (Director of Infection Control and Prevention Section, National Cancer Center Hospital East / Department of General Internal Medicine, National Cancer Center Hospital East /Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital) reports on a case of “A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment.”
For further information, please see the case study below.
Top Research & Recommendations Posts
- [Recommendations] The Future of Dementia Policy 2022: Deepening Dementia Policies Centered on People Living with Dementia and their Families to Lead Global Society (July 13, 2022)
- [Case Study] Keiji Okinaka “A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment” (AMR Alliance Japan, September 6, 2021 )
- [Case Study] Takashi Ueda “Candidemia Requires Routine Ophthalmologic Evaluation!” (AMR Alliance Japan, November 18, 2021)
- [Publication Report] The Future of the Healthcare System Project Presents “Partnership for Health System Sustainability and Resilience” Report (December 5, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan


